Zosano Pharma Corporation logo

ZSAN

NASDAQ

Zosano Pharma Corporation

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2015
Website
News25/Ratings1

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Latest news

25 items